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SUMMARY 
Evidence from genetic research, monoamine studies and psychopharmacological trials points towards 
a possible biological predisposition and precipitant for suicidal behaviour. The implications for early detec-
tion and management based on a biological model have been discussed. The limitations of the model have 
been discussed. 
Psychoanalytically suicide is an in-
wardly directed aggression against an in-
ternalized object. (Freud 1917). Ringel 
(1976) postulates a 'presuicidal syn-
drome', a form of a chronic neurosis that 
predisposes to suicide and whose fea-
tures comprise constriction of affect, val-
ues and social relations, a reversal of ag-
gression and suicide phantasies. Feelings 
of guilt, ideas of hopelessness and 
helplessness have been found to be 
strong potentials for suicide. (Beck et al 
1985). Mental illness especially Affective 
Disorder of depressive type, personality 
disorder and schizophrenia also even-
tuate in suicide in some cases. There are 
clinical predictors of suicide risk within 
the symptom constellation of depressive 
illness. The intensity of depression used 
to be judged by patient's expression of 
suicidal thoughts and the suicide at-
tempt. However, a lack of clear correla-
tion between the thoughts and the at-
tempt on the one hand and the severity of 
depression on the other is being recog-
nised. The superiority of Montgomery 
and Asberg's (1979) scale over the con-
ventional HRSD has been demonstrated 
in detecting this anomaly. 
During the last over two decades, the 
monoamine theory of affective illness has 
been having its sway and naturally biologi-
cal accompaniments of suicide behaviour 
became the focus of research. Con-
sequently a biological construct of suicide 
behaviour is being worked out. There are 
still many gaps. Such a formulation how-
ever does not negate the importance of 
psychological and social factors involved in 
suicide behaviour. This presentation offers 
certain psychobiological facets of suicide 
behaviour extracted from the available lit-
erature at present. 
Genetic Studies 
Though the occurrence of suicidal 
deaths in families has been noted over the 
years, cultural and psychological attributes 
shared by the members were considered 
significant overlooking the genetic role. In 
1947, Franz Kallman could not observe 
any concordance for suicide in his classic 
work on twins, although he found high 
concordance for schizophrenia and manic 
depressive illness in MZ twins (Kety, 
1985). Twenty years later, in a meta-
analysis of many studies, Haberlandt 
found 18% concordance rate for suicide 
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among the monozygotic twins (Kety 1985). 
In 1970, Juel-Nielsen found a significant 
concordance rate in monozygotic twin 
pairs dying through suicide (Kety 1985). 
In a study using the National Health Re-
gistry data of the Danish citizens, Schul-
singer identified 57 adoptees born bet-
ween 1925-48 who had committed suicide 
by the late 1960's. Victims' family his-
tories revealed the incidence of suicide 
among biological relations to be 4.5% in 
contrast to an incidence of less than 1% 
among the biological relations of a 
matched controlled group. There were 
no suicides among the adopted relatives 
of either group. (Kety 1985). An investi-
gation by Kety revealed 19 suicides among 
all relatives of the adoptees of whom 15 
were by biological parents, siblings and 
half siblings of the depressed adoptees. 
The highest incidence of suicide was noted 
among the biological relatives of those 
suicides in whom the diagnosis of affective 
disorder was made. The current studies 
though not indicative of an exclusive gene-
tic determinism of suicide behaviour, ena-
ble one to conclude that "among people 
who have a life experience that could lead 
to suicide, only those with the genetic pre-
disposition will actually do so" (Kety 
1985). Kety (1985) has summarised the 
contemporary research on the genetics of 
suicide behaviour. There are other reports 
that tend to confirm these findings (Venk-
oba Rao et al 1987 under publication). 
Endocrines and Neurotransmitters 
More than two decades age, Bunney 
et al (1965) demonstrated an increased uri-
nary excretion of Cortisol metabolites in 
the depressed suicidal subjects. Bunney 
and Fawcet (1965) observed a high risk for 
suicide in those with an elevated plasma 
Cortisol and urinary steroids. They attri-
buted this risk to an increased 'emotional 
turmoil' in the patients. Currently, this is 
explained on the basis of the changes in the 
hypothalmic pituitary adreno-cortex axis 
(Sachar 1976; Carroll et al 1976). Though 
there is an increased Cortisol in the depres-
sives, there are no clinical features of 
hypercorticalism. Cushing Syndrome is oc-
casionally complicated by suicide, espe-
cially the hypothalmic type in which 
psychiatric manifestations are common. 
There are reports on Dexamethasone Sup-
pression Test in suicide attempters. In a 
series of 17 patients who made suicide at-
tempts, 14 were found to be the non-sup-
pressors' in contrast to 9 out of 32 depres-
sive patients, who had not made suicide at-
tempts. It is not clear whether non-sup-
pression is specific for the diagnosis of de-
pression or the psychological state in which 
people commit suicide (Targum 1985). 
Those DST non-suppressors on clinical im-
provement, failing to convert to suppres-
sors fared badly in terms of relapses or 
suicide behaviour. In these cases relapses 
or repetition of suicide attempts were 
found to be common (Coryell and Schles-
ser 1981). Carroll et al. (1981) advocate 
that DST is to be done 48 hours following 
suicide attempts. Regarding the question 
as to how long it would take for DST to be 
normal following the suicide attempt, it 
depends upon the nature of the stress that 
prompted the attempt. There are reports 
of suicide following serial DST. For in-
stance, 3 completed suicide have occured 
next morning following dexamethasone 
test (Targum 1985). Suicide figures as an 
important terminator of myxoedema. 
Amine hypothesis explains the affec-
tive disorders of mania and depression on 
the basis of elevated or decreased levels of 
indoleamines and/or catecholamines in the 
central synaptic sites. It is the functional 
balance between these biogenic amines 
rather than their absolute excess or defi-
ciency that is of pertinence. A low level of 
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depressives especially indulging in violent 
forms of suicidal behaviour has ben a con-
sistent finding in a number of well designed 
studies (Asberg et al 1976; Traskman et 
al 1981, Asberg and Traskman 1979). 
Low levels of serotonin have been re-
ported in the hind brains on autopsy on 
suicidees in a project by the Medical Re-
search Council of Great Britain (Shaw et al 
1967) and of 5HIAA from the NIMH, 
Bethesda (Bourne et al, 1968). Lloyd et al. 
(1974) in a study of discrete brain areas 
found that serotonin levels were reduced 
significantly in the raphe nuclei dorsalis 
and centralis inferior. They also studied 
higher brain stem and telencephalon, 
where they found normal concentrations 
of serotonin but possibly increased 5 
HIAA in the mamillary bodies. Bourne et 
al (1968) found no abnormality in 
hypothalmic and hind brain NE or in caud-
ate dopamine concentrations. The as-
sociated occurrence of the low levels 
homovanillic acid, the metabolite of 
dopamine in CSF of the depressed suicidal 
probands was reported by Asberg and 
Traskman (1979) and Montgomery and 
Montgomery (1983). 
Serotonin deficiency is known to be 
associated with diverse forms of aggressive 
behaviour. In depression, aggression 
turned inwards results in suicide. It is also 
not uncommon to find depressives display 
aggression externally. The potential 
suicide is known to entertain death wishes 
against others. Murderous acts preceding 
suicide in the depressives are not uncom-
mon (Rosenbaum 1983). That a large 
number of suicide attempters have been 
destructive towards others has been com-
mented upon by Shafii (1986). Brown and 
his co-workers (1979) reported on the low 
CSF 5 HIAA in the military personnel with 
'hostile outbursts'. A significant relation-
ship was found between Rorschach pro-
tocols on aggressive drives and low CSF 5 
HIAA (Rydih et al quoted by Asberg and 
Traskman, 1979). A decrease turnover of 
serotonin in certain types of aggressive be-
haviour in animals has been reviewed by 
Eichelman (1979) and Delini-Stula and 
Vassout (1979). 
Lapin and Oxenkrug (1969) and Cur-
zon (1972) have hypothesised that ele-
vated Cortisol levels cause a decrease in 
serotonin synthesis by diminishing the av-
ailability of tryptophan through its action 
on tryptophanpyrrolase. Alternatively, 
monoamines may be involved in the con-
trol of the corticotropin releasing factor 
too (Weiner and Ganong 1978). The corre-
lation between lowered 5 HIAA and high 
suicide rates has been noted in 20% of all 
the patients studied. At present, the con-
clusion on the relationship is "a lot of 
people with low serotonin do not kill them-
selves, but none with high levels did". 
(Goodwin 1985). It is not yet clear whether 
a low serotonin is an indicator of severity 
of depression, or suicide behaviour or ag-
gression. 
Buchsbaum et al (1976) observed an 
increased incidence of suicide behaviour in 
the relatives of the probands with a low 
platelet MAO activity. Such a relation was 
also noticed in the psychiatrically ill pa-
tients by Buchsbaum et al (1977). Gottfries 
et al (1980) reported on the alcoholics who 
died from suicide showing low MAO activ-
ity have been reported by Schooler et al 
(1978) in the normal, non case persons. 
These included suicidal behaviour and 
other anti-social activities. It is likely that 
MAO activity and Cortisol secretion are re-
lated to serotonin turn-over. A low platlet 
MAO may serve as a predictor of suicide 
risk in the depressed subjects. 
A low melatonin syndrome of depres-
sion has been documented by Beck-Friis 
(1983) and Wetterberg et al (1981). Friis' 
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Venkoba Rao et al (1984) reported on the 
depressives with differing levels of urinary 
melatonin and their association with suici-
dal behaviour. With antidepressant 
therapy, and with the clinical improve-
ment the melatonin levels reverted to nor-
mal. The failure to return to normal de-
noted a tendency to relapse. The low 
melatonin may reflect the low serotonin 
turnover since serotonin is the precursor of 
melatonin and it may also indicate a low 
noradrenergic tone. The difference bet-
ween these reports in respect of suicide 
risk with low melatonin has been com-
mented upon by Venkoba Rao (1986). 
Seasonality in the occurrence of 
suicide has been reported, its peaks occur-
ring in late spring and early summer 
(Kevan 1980; Aschoff 1981). Such regular 
variation has been observed in mental hos-
pital admissions, use of ECT and other 
psychiatric therapies in affective disorders. 
Circannual rhythms of pineal function in 
animals have been observed and a seasonal 
alteration in the weights of the pineal in the 
humans on autopsy have been recorded 
(Wetterberg 1978). Beck-Feriis et al 
(1984) reported on the seasonal variation 
in melatonin secretion in man. There is 
thus a close parallel between neuroendoc-
rinological changes and monoamine 
metabolites on the one hand and suicide be-
haviour on the other. However not all de-
pressives display a low 5 HIAA profile. In 
many others, the levels are normal or even 
elevated. This highlights the heterogenous 
nature of clinical depression. 
Nondepressive suicide behaviour 
Suicide is not to be equated with de-
pressive illness, though earlier researchers 
emphasised depression and alcoholism as 
twin major contributors to suicide. There 
are, doubtless, causes other than these. 
Personality disorder is equally important 
among those who attempt or complete 
suicide (Venkoba Rcio 1986; Kreitman 
1977; Shaffer 1986). In Shaffer's series, 
cases of personality disorders outnum-
bered the depressives (DSM III category). 
The problems were antisocial and of con-
duct, and the use of drugs with the at-
tempts being invariably impulsive. 
A significant reduction of 5 HIAA in 
the CSF was observed in many suicide 
cases in the absence of depression, al-
coholism, Schizophrenia and Organic syn-
dromes. In many of these instances, 
psychopathology failed to conform to the 
conventional psychiatric diagnostic 
categories. Thus a low CSF 5 HIAA seems 
to link itself with suicide behaviour, irres-
pective of the underlying diagnosis. In-
terestingly Montgomery and Montgomery 
(1983) have pointed to possible low HVA 
levels in the nondepressive suicide at-
tempters bringing them on par with the de-
pressive suicides. They drew upon the be-
neficial effect from drugs which elevated 
dopamine in these cases though the CSF 
did not reveal such deficit. Further work is 
called for in this area. 
Measures to elevate monoamine levels 
Prevention of suicide is a complex af-
fair and it is difficult to accomplish this in 
any appreciable way - especially its prim-
ary prevention. During recent years phar-
macoprophylaxis of suicide has been possi-
ble. Treatment of suicide behaviour in de-
pression calls for treatment of depression 
itself. Lithium and tricyclics have proved 
useful as long term prophylactics against 
suicide (Venkoba Rao et al 1982; Barrac-
lough 1972; Prien 1979). Lithium nonres-
ponders are known to be susceptible to 
carbamazepine (Grof 1983). In view of the 
low 5 HIAA and HVA in the CSF of espe-
cially the depressives and of 5 HIAA in 
nondepressive suicides, newer strategies 
aiming at elevating them are available. A. VENKOBA RAO 
Zimelidine, a bicyclic antidepressant is a 
powerful inhibitor of uptake of serotonin 
(Coppen et al 1979). It has proved superior 
to amitriptyline in raising the 5 HIAA 
levels in the earlier stages of treatment of 
the depressed suicidal patients 
(Montgometry et al 1981). This is the anti-
depressent of choice when a quick effect is 
desirable. 
Management of suicide behaviour in 
personality disorder in fraught with dif-
ficulties owing to non-cooperation, hostil-
ity and non-compliance factors. The com-
parative superiority of flupenthixol over 
mianserin and placebo in these cases has 
been reported by Montgomery, Roy and 
Montogmery (1981). FlupenthixoFs action 
is mediated through dopamine without in-
volving 5 HIAA. Although there was no 
demonstrable change in CSF HVA levels 
in non-depressive suicidals, these authors 
speculate such an abnormality from the 
observed benefits from flupenthixol. This 
opens up a new field of pharmacotherapy 
in suicide behaviours of the personality 
disordered individuals. 
Suicide is a well-recognised dreaded 
complication of depression on responsive 
to conventional antidepressant drugs. Fai-
lure of the levels of CSF monoamines to 
rise by pharmacotherapy is noticed in 
these patients. ECT has been used on such 
non-responders to tricyclics and MAOI, 
with dramatic effects resulting in elevation 
of CSF monoamine metabolites (NIMH 
1985 personal communication). The use of 
ECT in cases of acute depression with 
suicide risk is established and needs no re-
petition. Thus newer measures to elevate 
the monoamine metabolite include 
Zimelidine and Flupenthixol. The oldest 
method of treatment - ECT - is now shown 
to do this in some refractory cases of de-
pression. It is to be cautioned that to ele-
vate serotonin level is not the aim in 
suicide prevention. The exact role of 
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serotonin in psychiatric illness awaits 
clarification. 
Newer Approaches 
Psychiatric research in recent years 
has shifted its focus towards the 'high risk' 
groups from the 'already ill' persons. Rec-
ognition of 'Subaffective disorder' as 
forerunner of syndromal affective disorder 
is an instance of such approach (Akiskal 
1981). Modern genetic research and un-
derstanding the monoamine metabolism in 
suicidal individuals, depressed as well as 
nondepressed, has given important leads 
to recognising the 'high risk' suicide prone 
individuals though a small group. A lower 
5 HIAA, HVA, melatonin levels and 
platalet MAO are likely to serve as traits 
(markers) that would enable identification 
of suicide proneness and institution of ap-
propriate treatment. Individuals with 
these traits are likely to react with suicidal 
behaviour under the impact of stressfur 
situation. To detect them will be a formid-
able undertaking on a large population. 
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